Loading page content...
Back to All Products
Gastroenterology View All Products
ESOSTART-40
A Leadwell Pharmaceuticals Brand
Advanced proton pump inhibitor for effective management of acid-related gastrointestinal disorders.
Marketed by Leadwell Pharmaceuticals
ESOSTART-40 contains Esomeprazole 40 mg, a proton pump inhibitor formulated to provide effective gastric acid suppression for the management of acid-related disorders.
Dosage Form
Gastro-Resistant Tablets
Category
Gastroenterology
Product Overview
About ESOSTART-40
ESOSTART-40 helps reduce gastric acid secretion, promoting relief from acid reflux symptoms and supporting the healing of gastric and duodenal ulcers. It is commonly prescribed for gastroesophageal reflux disease (GERD) and other acid-related gastrointestinal conditions.
Formula
Composition
IngredientQuantity
Esomeprazole40 mg
Ingredient Profile
Key Ingredients
Esomeprazole
A proton pump inhibitor that suppresses gastric acid secretion and promotes healing of acid-related gastrointestinal disorders.
Product Highlights
Why This Formulation
Provides long-lasting gastric acid suppression
Supports healing of gastric and duodenal ulcers
Effective in the management of GERD
Helps relieve heartburn and acid reflux
Once-daily proton pump inhibitor therapy
Product Information
Used in the management of Gastroesophageal Reflux Disease (GERD), gastric ulcers, duodenal ulcers, erosive esophagitis, Zollinger-Ellison syndrome and other acid-related disorders, as directed by a registered healthcare professional.
Directions for Use
Use only as directed by a registered healthcare professional.
Storage
Store in a cool and dry place, protected from direct sunlight and moisture. Keep out of reach of children.
For the use of a registered medical practitioner, hospital or laboratory only. This information is intended for healthcare professionals and educational purposes. It is not a substitute for medical advice, diagnosis or treatment.
Explore More
Related Products
Gastroenterology
ESOSTART-DSR
ESOSTART-DSR is a combination of Esomeprazole Enteric Coated 40 mg and Domperidone Sustained Release 30 mg formulated for the management of acid-related gastrointestinal disorders.
View ProductGastroenterology
DEXLEAD-DSR
DEXLEAD-DSR is a prescription gastrointestinal formulation combining Dexrabeprazole Modified Release with Domperidone Sustained Release to support acid suppression and gastric motility in patients with acid-related disorders.
View Product